drugset / Trial / NCT00465621
Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
RandomizedSingle-groupDouble-blindTreatment
Summary
The purpose of thie study is to compare the safety and IOP-lowering efficacy of AL-37807 Ophthalmic Solution 0.05%, 0.1% and 0.2% dosed QD AM to Xalatan dosed QD PM and Vehicle in patients with open-angle glaucoma or ocular hypertension
Timeline
- Start
- 2007-03
- Primary completion
- 2007-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AL-37807 | Unknown | 0.05 % | Other |
| Subject | AL-37807 | Unknown | 0.1 % | Other |
| Subject | AL-37807 | Unknown | 0.2 % | Other |
| Subject | Latanoprost | Small molecule | — | — |